Cell Signalling Pathways in Development and Disease: A Review
Abstract
Cell signalling pathways represent fundamental molecular communication networks that orchestrate cellular functions in development and disease. This comprehensive review examines the intricate landscape of cell signalling mechanisms in Nigerian populations, revealing distinct genetic, environmental, and clinical characteristics that significantly influence pathway behaviours and disease manifestations.
Through a systematic literature review, we analysed major signalling pathways, including Receptor Tyrosine Kinase (RTK), G-Protein-Coupled Receptor (GPCR), JAK-STAT, Wnt, Notch, and Hedgehog signalling, across both developmental and pathological contexts. Our investigation uncovered population-specific variations that profoundly impact disease susceptibility, progression, and treatment responses in Nigerian healthcare settings.
Key findings demonstrate that Nigerian populations exhibit unique alterations in signalling pathways driven by genetic polymorphisms, endemic infectious disease exposures, and environmental factors. Developmental signalling mechanisms revealed distinctive patterns of embryonic development, neural patterning, and stem cell regulation. In disease contexts, significant molecular variations were observed in cancer, metabolic disorders, inflammatory conditions, neurodegenerative diseases, and cardiovascular disorders.
The research highlights critical challenges in implementing signalling-targeted therapies, including infrastructure limitations, economic constraints, and regulatory complexities. Additionally, traditional Nigerian medicinal approaches offer promising complementary insights into the modulation of signalling pathways.
This review establishes a comprehensive framework for understanding cell signalling pathways in Nigerian populations, emphasising the importance of contextually specific molecular research. The findings provide essential guidance for developing precision medicine approaches tailored to local genetic and environmental contexts, ultimately supporting more effective disease prevention, diagnosis, and treatment strategies.
Keywords
Full Text:
PDFReferences
1. Kelly, D. E., Ramdas, S., Ma, R., Rawlings-Goss, R. A., Grant, G. R., Ranciaro, A., Hirbo, J. B., Beggs, W., Yeager, M., Chanock, S., Nyambo, T. B., Omar, S. A., Woldemeskel, D., Belay, G., Li, H., Brown, C. D., & Tishkoff, S. A. (2023). The Genetic and Evolutionary Basis of Gene Expression Variation in East Africans. Genome Biology, 24(1). doi 10.1186/s13059-023-02874-4
2. Su, J., Song, Y., Zhu, Z., Huang, X., Fan, J., Qiao, J., & Mao, F. (2024). Cell–cell communication: new insights and clinical implications. Signal Transduction and Targeted Therapy, 9(1). doi: 10.1038/s41392-024-01888-z
3. Adeyemo, A. A., Amodu, O. K., Ekure, E. E., & Omotade, O. O. (2018). Medical genetics and genomic medicine in Nigeria. Molecular Genetics & Genomic Medicine, 6(3), 314–321. doi: 10.1002/mgg3.419
4. Banerjee, S., Biehl, A., Gadina, M., Hasni, S., & Schwartz, D. M. (2017). JAK–STAT Signalling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects. Drugs, 77(5), 521–546. doi: 10.1007/s40265-017-0701-9
5. Ansari-Pour, N., Zheng, Y., Yoshimatsu, T. F., Sanni, A., Ajani, M., Reynier, J., Tapinos, A., Pitt, J. J., Dentro, S., Woodard, A., Rajagopal, P. S., Fitzgerald, D., Gruber, A. J., Odetunde, A., Popoola, A., Falusi, A. G., Babalola, C. P., Ogundiran, T., Ibrahim, N., Olopade, O. I. (2021). Whole-genome analysis of Nigerian patients with breast cancer reveals ethnic-driven somatic evolution and distinct genomic subtypes. Nature Communications, 12(1). doi: 10.1038/s41467-021-27079-w
6. Abiodun, M., & Oluwafemi, R. (2019). Incidence, spectrum and outcome of congenital anomalies seen in a neonatal intensive care unit in Southern Nigeria. Nigerian Postgraduate Medical Journal, 26(4), 239. doi: 10.4103/npmj.npmj_77_19
7. Zhu, F., Yan, H. H. N., Tong, Y., & Zhao, Y. (2025). Exploring WNT pathway dysregulation in serrated colorectal cancer for improved diagnostic and therapeutic strategies. Frontiers in Genetics, 16. doi: 10.3389/fgene.2025.1586867
8. Yang, S. X., Polley, E., & Lipkowitz, S. (2016). New insights on PI3K/AKT pathway alterations and clinical outcomes in breast cancer. Cancer Treatment Reviews, 45, 87–96. doi: 10.1016/j.ctrv.2016.03.004
9. Odewusi, O., Uzowa, C., Adetunji, F., Olaniyan, O., Obadire, O., & Sokunbi, Z. (2023). An assessment of the relationship between essential hypertension, NF-ΚB transcription factor and oxidative stress. Zenodo (CERN European Organisation for Nuclear Research). doi: 10.5281/zenodo.7976083
10. Lecarpentier, Y., Schussler, O., Hébert, J., & Vallée, A. (2020). Molecular Mechanisms Underlying the Circadian Rhythm of Blood Pressure in Normotensive Subjects. Current Hypertension Reports, 22(7). doi: 10.1007/s11906-020-01063-z
11. Arunsi, U. O., Chioma, O. E., Etusim, P. E., & Owumi, S. E. (2022). Indigenous Nigerian Medicinal Herbal Remedies: A Potential Source For Therapeutic Against Rheumatoid Arthritis. Experimental Biology and Medicine, 247(13), 1148–1178. doi: 10.1177/15353702221102901
12. Isah, M. B., Muhammad, Z., Lawan, M. M., Alkhamis, A. I., Goni, B. W., Oakley, S. S., Marshall, K., Hartig, R., Raouf, I. S., Yoshimatsu, T., Chagas, A. M., & Maina, M. B. (2024). Setting up a state‐of‐the‐art laboratory in resource-limited settings: A case study of the biomedical science research and training centre in Northeast Nigeria. European Journal of Neuroscience, 59(7), 1681–1695. doi: 10.1111/ejn.16260
13. Mbah, C. A., Okonkwo, S. C., Nwaume, E. J., Olawoore, F. R. & Abah, E. I. (2025). Traditional African Medicinal Plants as Potential Sources of Anticancer Agents: Bioactive Compounds, Mechanisms, and Future Directions. International Journal of Research Publication and Reviews, 6(5), 11679–11691. doi: 10.55248/gengpi.6.0525.18121
Article Metrics
Metrics powered by PLOS ALM
Refbacks
- There are currently no refbacks.
Copyright (c) 2025 Olasoji O. Agboola, David T. Ovioke

This work is licensed under a Creative Commons Attribution 4.0 International License.



